This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Introduction Atrialfibrillation is the most prevalent sustained arrhythmia worldwide and is expected to increase substantially within the coming years. Eligible patients are randomised 1:1 to either a combined supervised and eHealth-based exercise intervention or usual care for 12 months.
Background The significance of stress-test induced arrhythmias has been examined in prior studies, but there is no clear consensus regarding its significance. Objectives To determine the significance of stress test-induced arrhythmias. Atrialarrhythmia during stress testing, on the other hand, shows no association with mortality.
Atrialfibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. It can be associated with reduced quality of life and complications such as heart failure and stroke. Pulmonary vein isolation (PVI) is the most effective treatment for rhythm control.
Patients with a common heart arrhythmia called AtrialFibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
BackgroundInstant atrialfibrillation termination (AFT) during radiofrequency ablation has been suggested as a predictor of prognosis in persistent atrialfibrillation (AF). The baseline conditions were similar, except that patients with AFT presented significantly lower left atrial diameter (LAD).
Atrialfibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrialfibrillation.
In adults with congenital heart disease (ACHD patients), atrialarrhythmias (AA) and heart failure (HF) are common. Early diagnosis and ECG documentation is therefore essential for arrhythmia management. Of these, AA is one of the leading causes for hospital admissions in ACHD care.
Nature Reviews Cardiology, Published online: 28 February 2024; doi:10.1038/s41569-024-01004-2 Atrialfibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. However, this reasoning disregards valuable data regarding early arrhythmia recurrences and their potential significance.
(MedPage Today) -- For patients undergoing catheter ablation for atrialfibrillation (Afib), there was no signal that a brief course of colchicine reduced atrialarrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.
Atrialfibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. Global epidemiology of atrialfibrillation: An increasing epidemic and public health challenge. Food & Drug Administration ( FDA ).
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrialfibrillation in the U.S. adult population.
IntroductionAtrial fibrillation (AF) is a prevalent cardiac arrhythmia and a significant contributor to cardioembolic stroke, a condition closely linked to cognitive decline. However, research reveals that AF itself is independently associated with an increased risk of cognitive impairment.
A new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrialfibrillation, the most common type of abnormal heart rhythm.
(MedPage Today) -- BOSTON -- For persistent atrialfibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one procedure regardless of antiarrhythmic.
BackgroundAtrial fibrillation (AF) is the most common arrhythmia worldwide. Data regarding AF screening in conflict countries emergency departments (ED) is lacking.MethodsWe included consecutive patients >40 years old who reported to the ED of a Syrian tertiary centre between July 2024 and September 2024.
BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues.
When atrialfibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.
Specific cardiovascular diseases, such as acute myocardial infarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed. Elevated risk of arrhythmias, particularly atrialfibrillation, correlated with occupational silica exposure.
Introduction Catheter ablation is an effective and safe strategy for treating atrialfibrillation patients. Method Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrialfibrillation recurrence following catheter ablation. years following catheter ablation.
Recent research has also found the incidence of atrialfibrillation (AFib), the most common type of irregular heart rhythm or arrhythmia, continues to rise, according to the study. Binge drinking (five drinks within two hours for men and four drinks within two hours for women) is common around the world.
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
AFIB/AFL – atrialfibrillation or atrial flutter episodes. Other times, an irregular recording can signal a medical emergency, such as a myocardial infarction or a dangerous arrhythmia. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.
Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrialfibrillation, pulmonary hypertension and those with left atrial dilatation.
Atrialfibrillation (AF) is a relatively prevalent arrhythmia in patients with kidney failure requiring dialysis, who face a high risk of stroke and bleeding, and anticoagulation is a challenging decision.
Atrial flutter and atrialfibrillation are 2 different cardiac arrhythmias, but occur frequently side by side in the same patient. Here is an example of how atrial flutter degenerataes into atrialfibrillation.
It is estimated that more than 12 million people in the United States will have AtrialFibrillation, or AFib in 2030. It is one of the most commonly diagnosed heart conditions and is characterized by an irregular heartbeat or rhythm, known as arrhythmia.
Atrialfibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrialfibrillation.
Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrialarrhythmia recurrence in patients with symptomatic paroxysmal atrialfibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy.
In this weeks View, Dr. Eagle looks at arrhythmia recurrence and rhythm control after catheter ablation for atrialfibrillation. He then discusses long-term outcomes in transthyretin amyloid cardiomyopathy in patients treated with tafamidis.
Despite early evidence of an antiarrhythmic role of n-3 PUFA in the prevention of sudden cardiac death and postoperative and persistent atrialfibrillation (AF), subsequent well-designed randomized trials have largely not shown an antiarrhythmic benefit.
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, too quickly or irregularly. It includes conditions like atrialfibrillation.
Arrhythmias, a group of disorders that disrupt the normal rhythm of the heart, can lead to serious health complications such as heart failure, stroke, and sudden death. The global prevalence of arrhythmias, particularly atrialfibrillation, is on the rise, contributing to substantial health and economic burdens.
Abstract Background and Aims Atrialfibrillation is the most prevalent cardiac arrhythmia, and catheter ablation (CA) has emerged as a viable treatment option for selected patients. However, its safety profile in liver cirrhosis (LC) populations remains underexplored.
Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrialfibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF. LBA presented a lower acute PVI rate per patients (CBA 97.0%
A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1 A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1
Typical atrial flutter commonly occurs in patients with atrialfibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. Patients who were screened for typical atrial flutter were included in the analysis ( n = 1,907).
Persistent cardiac arrhythmias are readily amenable to detection by performing a standard electrocardiogram (ECG), but detection of transient (paroxysmal) arrhythmias has long been a significant cause of frustration to both doctors and patients. This article aims to provide a helpful overview for patients and doctors advising them.
The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrialfibrillation (AFib) and other arrhythmias linked to recurrent stroke risk.
Atrialfibrillation is the most prevalent sustained cardiac arrhythmia and an important risk factor for ischemic stroke resulting in a fivefold increased stroke risk. The clinical utility of polygenic risk scores for ischemic stroke prediction among atrialfibrillation patients has not yet been established.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content